You have   6 free profiles   left this month    Start Your Free Trial ➤
Hey, we noticed you're a RelSci Pro subscriber! Would you like to view the page there? View on RelSci Pro ➤

Thomas P. Mathers

Former President, Chief Executive Officer & Director at CoLucid Pharmaceuticals, Inc.
Relationship Science aggregates deep and verified information on over 6 million influential decision makers and the over 1.5 million organizations with which they are associated. From this data, we create a "business social graph" that highlights who knows whom. Here are Thomas P. Mathers's strongest connections.

People Most Closely Connected to Thomas P. Mathers

Click the names below to expand relationship details.
Art Pappas
Managing Partner at Pappas Capital
Darren J. Carroll
Senior Vice President of Corporate Business Development at Eli Lilly & Company
Joshua L. Smiley
Senior Vice President & Chief Financial Officer at Eli Lilly & Company
Eric H. Zanelli
Founder at D├ęclion Pharmaceuticals, Inc.
James F. White
Former Chief Operating Officer at Hypnion, Inc.
Barbara H. Wells
Director & Vice Chairman-Food Governing Body at Biotechnology Innovation Organization
Gil Van Bokkelen
Co-Founder at Athersys, Inc.
Sean A. McCarthy
President & Chief Executive Officer at CytomX Therapeutics, Inc.
Mike Raab
President & Chief Executive Officer at Ardelyx, Inc.
Russell H. Herndon
President & Chief Executive Officer at Hydra Biosciences, Inc.
David Stack
Chief Executive Officer at Pacira Pharmaceuticals Inc.
Paul J. Hastings
Former Chairman, President & Chief Executive Officer at OncoMed Pharmaceuticals, Inc.
Mark Corrigan
Former President & Chief Executive Officer at CombinatoRx, Inc.
Marvin L. White
President, Director & Chief Executive Officer at Aptevo Therapeutics, Inc.
Martin Bott
Vice President of Corporate Finance & Investment Banking at Eli Lilly & Company
Martin Edwards
Senior Partner NOVO Ventures at Novo Holding A/S
P. Kay Wagoner
Director-Emerging Companies Section at Biotechnology Innovation Organization
Richard J. Markham
Partner at Care Capital
992 more connections are available with a RelSci Professional subscription.